Lysine demethylase KDM5B down‐regulates SIRT3‐mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy

Diabetic peripheral neuropathy (DPN) is a common neurological complication of diabetes mellitus without efficient interventions. Both lysine demethylase 5B (KDM5B) and sirtuin‐3 (SIRT3) have been found to regulate islet function and glucose homeostasis. KDM5B was predicted to bind to the SIRT3 promoter by bioinformatics. Here, we investigated whether KDM5B affected DPN development via modulating SIRT3.

[1]  Hao Chang,et al.  Genetic Manipulation of Sirtuin 3 Causes Alterations of Key Metabolic Regulators in Melanoma , 2021, Frontiers in Oncology.

[2]  Wei Song,et al.  Quercetin Attenuates Diabetic Peripheral Neuropathy by Correcting Mitochondrial Abnormality via Activation of AMPK/PGC-1α Pathway in vivo and in vitro , 2021, Frontiers in Neuroscience.

[3]  Lanfang Li,et al.  Sirtuin 3 Alleviates Diabetic Cardiomyopathy by Regulating TIGAR and Cardiomyocyte Metabolism , 2021, Journal of the American Heart Association.

[4]  Yuan Yang,et al.  SIRT3 deficiency increases mitochondrial oxidative stress and promotes migration of retinal pigment epithelial cells , 2021, Experimental biology and medicine.

[5]  Waleed Hassan Almaliki,et al.  The emerging potential of SIRT-3 in oxidative stress-inflammatory axis associated increased neuroinflammatory component for metabolically impaired neural cell. , 2020, Chemico-biological interactions.

[6]  L. Ho,et al.  Sirt3 regulates adipogenesis and adipokine secretion via its enzymatic activity , 2020, Pharmacology research & perspectives.

[7]  Xu Shen,et al.  Antispasmodic Drug Drofenine as an Inhibitor of Kv2.1 Channel Ameliorates Peripheral Neuropathy in Diabetic Mice , 2020, iScience.

[8]  Yue Zhou,et al.  Ginsenoside Rg1 Performs Anti-Aging Functions by Suppressing Mitochondrial Pathway-Mediated Apoptosis and Activating Sirtuin 3 (SIRT3)/Superoxide Dismutase 2 (SOD2) Pathway in Sca-1+ HSC/HPC Cells of an Aging Rat Model , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[9]  E. Selvin,et al.  Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes , 2019, Current Diabetes Reports.

[10]  C. Ling,et al.  The Lysine Demethylase KDM5B Regulates Islet Function and Glucose Homeostasis , 2019, Journal of diabetes research.

[11]  Hong-Sheng Zhang,et al.  KDM5B promotes breast cancer cell proliferation and migration via AMPK‐mediated lipid metabolism reprogramming , 2019, Experimental cell research.

[12]  K. Chandrasekaran,et al.  Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway. , 2019, International review of neurobiology.

[13]  Hui-Chun Yu,et al.  Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[14]  I. Wilkinson,et al.  A new look at painful diabetic neuropathy. , 2018, Diabetes research and clinical practice.

[15]  Guoliang Meng,et al.  Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3‐dependent manner , 2018, British journal of pharmacology.

[16]  H. Ren,et al.  Exogenous H2S switches cardiac energy substrate metabolism by regulating SIRT3 expression in db/db mice , 2018, Journal of Molecular Medicine.

[17]  M. Carrì,et al.  SIRT3 and mitochondrial metabolism in neurodegenerative diseases , 2017, Neurochemistry International.

[18]  Benjamin L. Kidder,et al.  H3K4 demethylase KDM5B regulates global dynamics of transcription elongation and alternative splicing in embryonic stem cells , 2017, Nucleic acids research.

[19]  L. Østergaard,et al.  PERIPHERAL NEUROPATHIES: Schwann cell interactions with axons and microvessels in diabetic neuropathy , 2017 .

[20]  C. Mendivil,et al.  Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy? , 2017, Journal of diabetes research.

[21]  Liping Han,et al.  Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1α-SIRT3 signaling pathway , 2016, International journal of molecular medicine.

[22]  R. Midha,et al.  Diabetic Schwann cells suffer from nerve growth factor and neurotrophin‐3 underproduction and poor associability with axons , 2013, Glia.

[23]  G. Du,et al.  Salvianolic Acid A Protects the Peripheral Nerve Function in Diabetic Rats through Regulation of the AMPK-PGC1α-Sirt3 Axis , 2012, Molecules.

[24]  M. Chopp,et al.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice , 2011, Neuroscience.

[25]  R. Freeman,et al.  Diabetic Neuropathy , 2010, Diabetes Care.

[26]  S. Chung,et al.  Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress , 2003, Molecular and Cellular Neuroscience.

[27]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[28]  D. Hale,et al.  An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. , 1990, Analytical biochemistry.

[29]  M. Pfeifer,et al.  Peripheral diabetic neuropathy. , 1988, The Medical clinics of North America.